"Wegovy: A Game-Changer in Obesity Treatment?"
Patients often struggle with nonadherence to prescribed medications, but the new obesity drugs Wegovy and Zepbound are showing exceptional compliance rates among users, with many intending to take them indefinitely. Unlike traditional medications, patients are often the ones seeking out obesity drugs after struggling with weight loss and regain. The drugs, while effective, come with drawbacks such as cost, availability issues, and side effects, but users are willing to endure these challenges due to the significant improvement in their quality of life and the elimination of obesity-related stigma and shame.
